Brokerages forecast that Kronos Worldwide, Inc. (NYSE:KRO) will report earnings per share (EPS) of $0.34 for the current quarter, Zacks reports. Two analysts have issued estimates for Kronos Worldwide’s earnings. Kronos Worldwide posted earnings per share of $0.67 in the same quarter last year, which indicates a negative year over year growth rate of 49.3%. The company is expected to issue its next quarterly earnings results on Tuesday, August 6th.
According to Zacks, analysts expect that Kronos Worldwide will report full year earnings of $1.05 per share for the current financial year, with EPS estimates ranging from $1.00 to $1.10. For the next fiscal year, analysts forecast that the company will post earnings of $1.46 per share, with EPS estimates ranging from $1.15 to $1.77. Zacks’ earnings per share calculations are a mean average based on a survey of sell-side research analysts that cover Kronos Worldwide.
Kronos Worldwide (NYSE:KRO) last posted its quarterly earnings data on Wednesday, May 8th. The specialty chemicals company reported $0.26 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.24 by $0.02. Kronos Worldwide had a net margin of 9.87% and a return on equity of 19.26%. The business had revenue of $436.50 million during the quarter, compared to the consensus estimate of $398.26 million.
NYSE:KRO opened at $13.63 on Tuesday. Kronos Worldwide has a 12 month low of $10.51 and a 12 month high of $22.96. The business’s fifty day moving average is $14.38. The company has a quick ratio of 2.93, a current ratio of 4.99 and a debt-to-equity ratio of 0.62. The firm has a market capitalization of $1.58 billion, a P/E ratio of 7.70, a P/E/G ratio of 0.83 and a beta of 2.00.
A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Alps Advisors Inc. lifted its position in Kronos Worldwide by 5.0% during the first quarter. Alps Advisors Inc. now owns 28,886 shares of the specialty chemicals company’s stock valued at $405,000 after purchasing an additional 1,384 shares during the period. Legal & General Group Plc lifted its position in Kronos Worldwide by 43.3% during the fourth quarter. Legal & General Group Plc now owns 4,660 shares of the specialty chemicals company’s stock valued at $54,000 after purchasing an additional 1,408 shares during the period. Northern Trust Corp lifted its position in Kronos Worldwide by 0.5% during the fourth quarter. Northern Trust Corp now owns 363,090 shares of the specialty chemicals company’s stock valued at $4,182,000 after purchasing an additional 1,783 shares during the period. Raymond James & Associates lifted its position in Kronos Worldwide by 10.5% during the fourth quarter. Raymond James & Associates now owns 20,325 shares of the specialty chemicals company’s stock valued at $234,000 after purchasing an additional 1,924 shares during the period. Finally, Bank of Montreal Can lifted its position in Kronos Worldwide by 35.5% during the first quarter. Bank of Montreal Can now owns 10,986 shares of the specialty chemicals company’s stock valued at $154,000 after purchasing an additional 2,881 shares during the period. Institutional investors own 20.36% of the company’s stock.
Kronos Worldwide Company Profile
Kronos Worldwide, Inc produces and markets titanium dioxide pigments (TiO2) in Europe, North America, the Asia Pacific, and internationally. It produces TiO2 in two crystalline forms, rutile and anatase to impart whiteness, brightness, opacity, and durability for various products, including paints, coatings, plastics, paper, fibers, and ceramics, as well as for various specialty products, such as inks, foods, and cosmetics.
Read More: FAANG Stocks
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Kronos Worldwide Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kronos Worldwide and related companies with MarketBeat.com's FREE daily email newsletter.